Affinity DataIC50: 4nMAssay Description:Antagonist activity at CRTh2 in human RBC assessed as inhibition of PGD2-induced eosinophil shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Antagonist activity at CRTh2 in human whole blood assessed as inhibition of PGD2-induced eosinophil shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Antagonist activity at CRTh2 in human RBC assessed as inhibition of PGD2-induced eosinophil shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Antagonist activity at CRTh2 in human whole blood assessed as inhibition of PGD2-induced eosinophil shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 87nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 160nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 220nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 240nMAssay Description:Antagonist activity at CRTh2 in human whole blood assessed as inhibition of PGD2-induced eosinophil shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 270nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 380nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 440nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 450nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 450nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 520nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 520nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 720nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by...More data for this Ligand-Target Pair